Inhaled nitric oxide use in preterm infants in California neonatal intensive care units.

Authors: 
S.C. Handley; R.H. Steinhorn; A.O. Hopper; B. Govindaswami; D.R. Bhatt; K.P. Van Meurs; R.L. Ariagno; J.B. Gould; H.C. Lee
Abstract: 

OBJECTIVE: To describe inhaled nitric oxide (iNO) exposure in preterm infants and variation in neonatal intensive care unit (NICU) use.

STUDY DESIGN: This was a retrospective cohort study of infants, 22 to 33+6/7 weeks of gestational age (GA), during 2005 to 2013. Analyses were stratified by GA and included population characteristics, iNO use over time and hospital variation.

RESULTS: Of the 65 824 infants, 1718 (2.61%) received iNO. Infants, 22 to 24+6/7 weeks of GA, had the highest incidence of iNO exposure (6.54%). Community NICUs (n=77, median hospital use rate 0.7%) used less iNO than regional NICUs (n=23, median hospital use rate 5.8%). In 22 to 24+6/7 weeks of GA infants, the median rate in regional centers was 10.6% (hospital interquartile range 3.8% to 22.6%).

CONCLUSION: iNO exposure varied with GA and hospital level, with the most use in extremely premature infants and regional centers. Variation reflects a lack of consensus regarding the appropriate use of iNO for preterm infants.

Citation: 

Handley SC, Steinhorn RH, Hopper AO, et al. "Inhaled nitric oxide use in preterm infants in California neonatal intensive care units." J Perinatol. 2016;36(8):635-9.PubMed

Publication type: 
Journal Article
Year: 
2016
CPQCC publication: 
Yes
CPQCC publications category: 
Assessment of quality of care and practice patterns
PubMed ID: 
27031320
PMCID: 
PMC4963282